摘要
浸润的巨噬细胞参与致病血管如新生血管性老年性黄斑变性(nAMD)。巨噬细胞来源于循环中的单核细胞和单核细胞的三个亚型存在于人类中:经典(CD14 + CD16 -),非经典(CD14-CD16 +)和中间(CD14+CD16+单核细胞)。本研究的目的是探讨循环单核细胞湿性年龄相关性黄斑变性(NAMD)的作用。流式细胞仪分析表明,来自于CX3CR1与HLA-DR表达水平较高的nAMD患者的中间的单核细胞与那些受到控制的变量相比。单核细胞从NAMD患者表示更高水平的磷酸化信号转导与转录激活因子3(PSTAT3),并产生VEGF含量较高。在脉络膜新生血管(CNV)的小鼠模型,PSTAT3表达在视网膜和RPE /脉络膜浸润的巨噬细胞表达增加,和49.24%PSTAT3的抑制细胞因子信号3(SOCS3)在LysM-Cre+/-:SOCS3fl/fl 基因缺失:导致小鼠自发性STAT3的活化,加速新生血管形成,抑制STAT3的活化利用小肽lll12抑制激光诱导的CNV。我们的研究结果表明,单核细胞特别是单核细胞的中间亚群在nAMD患者中间被激活。循环中的单核细胞STAT3的激活可能有助于在AMD脉络膜新生血管的发展。
关键词: 巨噬细胞,单核细胞,血管生成,视网膜,年龄相关性黄斑变性,细胞因子。
Current Molecular Medicine
Title:STAT3 Activation in Circulating Monocytes Contributes to Neovascular Age-Related Macular Degeneration
Volume: 16 Issue: 4
Author(s): M. Chen, J. Lechner, J. Zhao, L. Toth, R. Hogg, G. Silvestri, A. Kissenpfennig, U. Chakravarthy, H. Xu
Affiliation:
关键词: 巨噬细胞,单核细胞,血管生成,视网膜,年龄相关性黄斑变性,细胞因子。
摘要: Infiltrating macrophages are critically involved in pathogenic angiogenesis such as neovascular agerelated macular degeneration (nAMD). Macrophages originate from circulating monocytes and three subtypes of monocyte exist in humans: classical (CD14+CD16-), non-classical (CD14-CD16+) and intermediate (CD14+CD16+) monocytes. The aim of this study was to investigate the role of circulating monocyte in neovascular age-related macular degeneration (nAMD). Flow cytometry analysis showed that the intermediate monocytes from nAMD patients expressed higher levels of CX3CR1 and HLA-DR compared to those from controls. Monocytes from nAMD patients expressed higher levels of phosphorylated Signal Transducer and Activator of Transcription 3 (pSTAT3), and produced higher amount of VEGF. In the mouse model of choroidal neovascularization (CNV), pSTAT3 expression was increased in the retina and RPE/choroid, and 49.24% of infiltrating macrophages express pSTAT3. Genetic deletion of the Suppressor of Cytokine Signalling 3 (SOCS3) in myeloid cells in the LysM-Cre+/-:SOCS3fl/fl mice resulted in spontaneous STAT3 activation and accelerated CNV formation. Inhibition of STAT3 activation using a small peptide LLL12 suppressed laserinduced CNV. Our results suggest that monocytes, in particular the intermediate subset of monocytes are activated in nAMD patients. STAT3 activation in circulating monocytes may contribute to the development of choroidal neovascularisation in AMD.
Export Options
About this article
Cite this article as:
M. Chen, J. Lechner, J. Zhao, L. Toth, R. Hogg, G. Silvestri, A. Kissenpfennig, U. Chakravarthy, H. Xu , STAT3 Activation in Circulating Monocytes Contributes to Neovascular Age-Related Macular Degeneration, Current Molecular Medicine 2016; 16 (4) . https://dx.doi.org/10.2174/1566524016666160324130031
DOI https://dx.doi.org/10.2174/1566524016666160324130031 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Smell and Taste Disorders Resulting from Cancer and Chemotherapy
Current Pharmaceutical Design Withdrawal Notice: Circulatory Cells as Tumortropic Carrier for Targetability Improvement
Current Drug Delivery Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors
Current Chemical Biology Pharmacogenetics of Phase I and Phase II Drug Metabolism
Current Pharmaceutical Design Current Strategies to Target the Anti-Apoptotic Bcl-2 Protein in Cancer Cells
Current Medicinal Chemistry High Throughput Study for Molecular Mechanism of Metformin Pre-Diabetic Protection <i>via</i> Microarray Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Gene Expression Abnormalities in Thymoma
Current Pharmacogenomics Natural and Synthetic Naphthoquinones Active Against Trypanosoma Cruzi: An Initial Step Towards New Drugs for Chagas Disease
Current Medicinal Chemistry Toxicities of Receptor Tyrosine Kinase Inhibitors in Cancer Pharmacotherapy: Management with Clinical Pharmacology
Current Drug Metabolism Design of Lamivudine Loaded Nanoparticles for Oral Application by Nano Spray Drying Method: A New Approach to use an Antiretroviral Drug for Lung Cancer Treatment
Combinatorial Chemistry & High Throughput Screening Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS Metastases: The Road less Travelled
Current Molecular Pharmacology MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview
Anti-Cancer Agents in Medicinal Chemistry Weka Machine Learning for Predicting the Phospholipidosis Inducing Potential
Current Topics in Medicinal Chemistry The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia
Current Medicinal Chemistry MicroRNA in the Pathogenesis and Prognosis of Esophageal Cancer
Current Pharmaceutical Design Arylurea Derivatives: A Class of Potential Cancer Targeting Agents
Current Topics in Medicinal Chemistry Molecular and Biochemical Changes of the Cardiovascular System due to Smoking Exposure
Current Pharmaceutical Design Metabolomics-based Approach to Pharmacotherapy Personalization: Advantages and Limitations
Current Pharmacogenomics and Personalized Medicine Interferon-α Treatment in Systemic Mastocytosis
Current Drug Targets Preface
Current Protein & Peptide Science